Fourth, many people believe that quitting smoking interferes with recovery from mental illness, eliminating a coping strategy and leading to decompensation in mental health functioning. Five randomized tobacco-treatment trials in patients concurrently receiving mental health treatment have found that smoking cessation did not exacerbate depression or PTSD symptoms or lead to psychiatric hospitalization or increased use of alcohol or illicit drugs. 1 Finally, some argue that smoking, which is perceived as having distal effects, is the lowest-priority concern for patients with acute psychiatric symptoms. Yet people with psychiatric disorders are far more likely to die from tobacco-related diseases than from mental illness. Smokers know tobacco use has deadly consequences and expect health care professionals to intervene. Indeed, raising the issue of tobacco use with patients enhances the rapport between patients and clinicians.
There is growing evidence that smokers with mental illness are as ready to quit as other smokers and can do so without any threat to their mental health recovery. Evidence supports the use of most recommended cessation treatments in smokers with mental illness (see table) .
Clinicians are therefore encouraged to ask all patients about tobacco use, advise smokers to quit, assess their readiness to quit, tailor assistance accordingly, and arrange for follow-up. Key strategies for smokers who are not ready to quit include focusing on the benefits of change and the risks associated with tobacco use, as well as addressing key barriers to cessation (e.g., stress, fear of weight gain, and nicotine withdrawal). Smokers who are ready to quit should be encouraged to set a quit date in the next 2 weeks, given a prescription for pharmacologic cessation treatment (unless it is contraindicated), and linked with counseling support. Mood-management strategies may also be helpful for smokers with current or past mental illness. Integrating cessation treatment into existing care results in greater engagement, greater use of cessation pharmacotherapy, and increased likelihood of abstinence. 3 Ongoing contact allows clinicians to monitor and address any changes in psychiatric symptoms during quitting attempts. Relapse rates may be high, and combined and extended use of cessation medications may be warranted.
There is a critical need to engage health care providers, policymakers, and mental health advocates in the effort to increase access to evidence-based tobacco treatment. The Joint Commission plans to adopt revised hospital standards for tobacco treatment next January. The standards should apply to all hospitalized smokers, regardless of mental health status. More generally, we need greater advocacy for smoke-free environments for mental health treatment; training for clinicians in cessation treatment; and systems for routinely identifying patients who smoke, advising cessation, and providing treatment or referral.
The history of tobacco use in the mental health field is long and troubling. It is time to make effective cessation treatments readily available to all smokers.
Disclosure forms provided by the author are available with the full text of this article at NEJM.org. welfare of the city's residents. Severe smog was a common occurrence. Today, throughout the United States, air quality has improved greatly, and the last century's severe, life-threatening episodes of air pollution, such as one that caused about 20 deaths in Donora, Pennsylvania, over a 3-day period in 1948, have largely been forgotten. The Clean Air Act of 1970 (CAA) has driven this progress, but we now face new challenges in air-quality management. The 20th-century pollution episodes and the pervasive smoke problem in cities motivated increasingly stringent and sweeping laws and programs to address air pollution. For more than 40 years, the CAA, aided by amendments passed in 1977 and 1990, has been the foundation for U.S. airquality management. It provides a broad regulatory framework, covering air-pollution standards, various stationary and mobile sources, acid deposition, and stratospheric ozone protection. Two sections of the law address the major pollutants in ambient air, including particulate matter, ozone, carbon monoxide, nitrogen dioxide, and sulfur dioxide, as well as lead, which ceased to be a widespread problem when it was removed from gasoline. These pollutants are referred to as "criteria pollutants," thanks to a passage in the law that requires the administrator of the Environmental Protection Agency (EPA) to issue "air-quality criteria," accurately reflecting the scientific evidence related to identifiable public health and environmental effects, for any substance designated as an air pollutant.
The CAA also requires the EPA administrator to set National Ambient Air Quality Standards (NAAQS) for pollutants for which air-quality criteria are listed. The language of the law on this point provides a strong public health mandate that has evolved through application and litigation. By intent, the NAAQS must protect susceptible groups within the U.S. population, although protection for the most susceptible may be unattainable. The achievement of what the CAA calls an "adequate margin of safety" does not imply that risk-free levels have been set, but that an acceptable level of risk has been reached, given uncertainties in the evidence. The costs of implementation and compliance are not to be considered in setting the NAAQS, although the law does call for costs to be considered in the setting of individual emission standards (e.g., for vehicles and electric utilities) that are intended to help meet the NAAQS. Under the CAA, the Clean Air Scientific Advisory Committee (CASAC, which I currently chair) provides peer review for the EPA's reports and analyses that support NAAQS revisions.
Over the 40 years since NAAQS were first promulgated, they have led to progressive reductions in levels of criteria pollutants (see graph). Economic analyses indicate that these reductions have been highly cost-effective. 1 However, as the EPA administrator now considers revisions to the NAAQS for particulate matter and ozone, the CAA's tenets are being questioned. The questions are motivated by the possibility that even lower concentrations for the NAAQS will be proposed, leading to the designation of large 1 9 9 8 1 9 9 7 1 9 9 6 1 9 9 5 1 9 9 4 1 9 9 3 1 9 9 2 1 9 9 1 1 9 9 0
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National Levels of the Six Criteria Pollutants, as Percentages of the Levels Set in the Most Recent National Ambient Air Quality Standards (NAAQS), 1990-2008.
PM 2.5 denotes particulate matter with particles less than or equal to 2.5 μm in aerodynamic diameter, PM 10 particulate matter with particles less than or equal to 10 μm in aerodynamic diameter, CO carbon monoxide, NO 2 nitrogen dioxide, and SO 2 sulfur dioxide. National levels are averages of levels provided by all monitors with complete data for the period. Air-quality data for PM 2.5 began to be collected in 1999. Data are from the U.S. Environmental Protection Agency. regions of the country as out of compliance with the law; such a result would carry implications for many municipalities and states and multiple U.S. industries. The evidence supporting lowering of maximum levels comes largely from epidemiologic studies showing that current levels of particulate matter and ozone are adversely affecting public health. Discussion of the NAAQS and the CAA has been further complicated by a U.S. Supreme Court finding that the EPA has authority to regulate greenhouse gas emissions.
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Over the remainder of 2011, the EPA's administrator, Lisa Jackson, will make key decisions with regard to lowering the NAAQS for particulate matter and ozone. For ozone, she has reopened the 2007 decision of then-administrator Stephen Johnson to set the standard at 0.075 ppm as the 8-hour average, which was made on the basis of the scientific evidence available at the time and the CASAC's recommendation that the limit be in the range of 0.060 to 0.070 ppm. Subsequently, the CASAC has reaffirmed that recommendation and answered additional questions about the scientific foundation for the ozone NAAQS. There is great interest in the administrator's final decision; in its teleconferences discussing the EPA's questions on ozone, the CASAC received input from 57 public commenters. Some raised concern that the evidence was still too uncertain to warrant lowering the NAAQS and that any mandated reduction would be costly and lead to the elimination of jobs, whereas others claimed that such a reduction was needed to meet the CAA's requirement for protecting public health. For particulate matter, a decision will be forthcoming by year's end with regard to recommended reductions in the 24-hour and annual NAAQS. If the administrator follows the CASAC's recommendations, the NAAQS will be set at lower levels for both particulate matter and ozone.
As the NAAQS have been reset at lower and lower concentrations, the gaps between acceptable concentrations and irreducible background levels have narrowed, raising the question of how much lower the limits can be pushed. For ozone and particulate-matter pollution, because no thresholds have been identified below which there is no risk at all, the EPA is using scenarios of risk and exposure to gauge the effects of setting the standards at various concentrations and giving consideration to the burden of avoidable disease. In promulgating the NAAQS for these pollutants, the administrator must weigh the public health burden against the uncertainty of the scientific evidence related to lower concentrations, keeping in mind the CAA's requirement for an adequate margin of safety. It is challenging for researchers to reduce this uncertainty, given the narrowing and low range of concentrations at issue and the difficulty of disentangling the effect of one pollutant from those of others.
As an alternative to regulating pollutants one at a timethe approach outlined in the CAA Amendments of 1990 -consideration is being given to multipollutant strategies that would enable the greatest possible reduction in the public health effects of the mixture of inhaled pollutants. 2 Exposure to trafficrelated pollution generally, for example, has adverse health effects but is not specifically addressed in the CAA. 3 Some multipollutant strategies have already been introduced. The CASAC has just reviewed a multi-pollutant approach for managing the combined effects of oxides of nitrogen and oxides of sulfur as they are deposited in sensitive aquatic ecosystems. 4 More integrated strategies for air-quality management might also improve control of greenhouse gas emissions, which come from the same sources as the criteria pollutants. New research approaches would be needed to support such integrated strategies. 5 Ongoing research may lead to more refined indicators for particulatematter pollution, to replace the current mass-based standard, which includes a mixture of particles from many sources.
Further interpretation or amendment of the CAA may eventually be needed to advance multi-pollutant air-quality management. Revised interpretation can be controversial and subject to legal challenge; amendments have been passed infrequently and cautiously in the past. But the individual-pollutant approach no longer accords as well with our scientific understanding of air pollution and its potential hazards for human and environmental health. More integrative strategies might well address air-quality problems extending from local to global levels. Any future Congressional action on the CAA should be consistent with the spirit of previous amendments, which recognized that U.S. standards for air quality should be grounded in the best available scientific evidence. Copyright © 2011 Massachusetts Medical Society. All rights reserved.
